[Federal Register Volume 89, Number 89 (Tuesday, May 7, 2024)]
[Notices]
[Pages 38151-38153]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09857]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-24-24FI; Docket No. CDC-2024-0036]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Comprehensive Evaluations of the 
Division for Heart Disease and Stroke Prevention Programs (WISEWOMAN, 
National CVH Program, Innovative CVH Program). The purpose of the data 
collection is to evaluate the implementation of evidence-based 
strategies within these programs, measure their impact on 
cardiovascular disease (CVD) prevention and management, and to identify 
strategies that are most effective in reaching populations 
disproportionately affected by CVD.

DATES: CDC must receive written comments on or before July 8, 2024.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0036 by either of the following methods:
     Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (www.regulations.gov) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and

[[Page 38152]]

    5. Assess information collection costs.

Proposed Project

    Comprehensive Evaluations of the Division for Heart Disease and 
Stroke Prevention Programs (WISEWOMAN, National CVH Program, Innovative 
CVH Program)--New--National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention (CDC) Division for 
Heart Disease and Stroke Prevention (DHDSP) are submitting this new 
three-year information collection request (ICR) for an evaluation of 
three recently launched cooperative agreements: Well-Integrated 
Screening of Women Across the Nation (WISEWOMAN), The National 
Cardiovascular Health Program (The National CVH Program), and The 
Innovative Cardiovascular Health Program (The Innovative CVH Program).
    The WISEWOMAN program supports the early detection and treatment of 
hypertension in low-income, uninsured, and underinsured participants, 
ages 35-64. The National CVH Program implements evidence-based 
strategies to manage CVD in populations impacted by the high prevalence 
of CVD, exacerbated by health inequities and disparities, emphasizing 
hypertension and high cholesterol control among adults aged 18-85. The 
Innovative CVH Program focuses on implementing innovative evidence-
based strategies to assess and address the health disparities and 
inequities in communities at highest risk (defined as census tracts 
with a crude hypertension prevalence of 53% or higher), where there is 
a particular need for equity-focused health system interventions to 
prevent, detect, control, and manage hypertension and high cholesterol. 
These three programs build upon CDC's previous work to identify 
promising CVD prevention and management practices and fund various 
organizations, including State and County governments, American Indian 
or Alaska Native tribal governments, non-government organizations, 
institutions of higher education, to implement evidence-based 
strategies in their jurisdictions. Since the programs are a substantial 
investment of federal funds, comprehensive evaluations are important to 
demonstrate the types of interventions being implemented and what is 
being accomplished using these funds.
    The comprehensive evaluation of these programs includes process and 
outcome evaluations, and a cross-program analysis to assess the unique 
contributions of each program towards evidence-based strategies, health 
equity advancement, and health system transformation over the five 
program years. The evaluation aims to describe the implementation of 
the programs, assess the extent to which short-term, intermediate, and 
long-term outcomes have been met, and estimate the costs involved in 
implementing the programs. The comprehensive evaluation is designed to 
complement the evaluations already being conducted by program 
recipients. The data collection focuses on obtaining qualitative and 
cost information at the organizational and community levels about 
strategy implementation, facilitators and barriers, and other 
contextual information that affects program implementation and 
participant outcomes. Data collection activities of the comprehensive 
evaluation include qualitative interviews for evaluability assessments, 
exploratory assessments, and cost data collected for a cost study. 
During the qualitative data collection, semi-structured interviews will 
be conducted with recipients, their partnering sites, and Learning 
Collaborative members, providing a multifaceted view of the program's 
implementation and outcomes. Cost data will be used to estimate the 
implementation costs and value of resources invested by program 
recipients and their partners. Cost data will be collected through a 
spreadsheet-based cost inventory tool, key informant interviews, and 
document reviews. There are no costs to respondents except their time. 
Data collection tools are crafted to ensure relevance and capture 
essential information needed to evaluate the effectiveness and impact 
of the program strategies, while minimizing respondent burden.
    The findings from the data collection will provide tailored, 
action-oriented, and timely recommendations for program improvement 
throughout the program period. Findings will foster documentation and 
sharing of lessons learned, contribute to the evidence base, and 
support replication and scaling of promising program strategies. 
Without collection of evaluative data, CDC will not be able to capture 
critical information needed to continuously improve programmatic 
efforts and clearly demonstrate the responsible use of federal funds.
    CDC requests OMB approval for an estimated 2,054 annual burden 
hours. There is no cost to respondents other than their time to 
participate.
    Estimated Annualized Burden Hours:

----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Recipients....................  Evaluability                  72               1             0.5              36
                                 Assessment
                                 Nomination
                                 Form_NCHP_ICHP.
                                Evaluability                  35               1             0.5            17.5
                                 Assessment
                                 Nomination
                                 Form_WW.
                                Eval Assessment               18               1             1.5              27
                                 CCL Recipient
                                 Interview Guide
                                 NCHP_ICHP.
                                Eval Assessment               18               1             1.5              27
                                 CQM Recipient
                                 Interview Guide
                                 NCHP_ICHP.
                                Eval Assessment               18               1             1.5              27
                                 TBC Recipient
                                 Interview Guide
                                 NCHP_ICHP.
                                Eval Assessment                8               1             1.5              12
                                 CCL Recipient
                                 Interview Guide
                                 WW.
                                Eval Assessment                8               1             1.5              12
                                 CQM Recipient
                                 Interview Guide
                                 WW.
                                Eval Assessment                8               1             1.5              12
                                 TBC Recipient
                                 Interview Guide
                                 WW.
                                Ex Assessment                  4               1             1.5               6
                                 CCL Recipient
                                 Interview
                                 Guide_WW.

[[Page 38153]]

 
                                Ex Assessment                  4               1             1.5               6
                                 CQM Recipient
                                 Interview
                                 Guide_WW.
                                Ex Assessment                  4               1             1.5               6
                                 TBC Recipient
                                 Partner
                                 Interview
                                 Guide_WW.
                                Ex Assessment                  9               1             1.5            13.5
                                 CCL Recipient
                                 Interview Guide
                                 NCHP_ICHP.
                                Ex Assessment                  9               1             1.5            13.5
                                 CQM Recipient
                                 Interview Guide
                                 NCHP_ICHP.
                                Ex Assessment                  9               1             1.5            13.5
                                 TBC Recipient
                                 Interview Guide
                                 NCHP_ICHP.
                                Cost Study                   165               1               1             165
                                 Interview
                                 Guide_Recipient.
                                Comprehensive                110               1             2.5             275
                                 Evaluation
                                 Resource Use
                                 and Cost
                                 Inventory
                                 Tool_Recipient.
                                Eval Assessment               18               1             1.5              27
                                 CCL Partner
                                 Interview Guide
                                 NCHP_ICHP.
                                Eval Assessment               18               1             1.5              27
                                 CQM Partner
                                 Interview Guide
                                 NCHP_ICHP.
                                Eval Assessment               18               1             1.5              27
                                 TBC Partner
                                 Interview Guide
                                 NCHP_ICHP.
                                Eval Assessment                8               1             1.5              12
                                 CCL Partner
                                 Interview Guide
                                 WW.
                                Eval Assessment                8               1             1.5              12
                                 CQM Partner
                                 Interview Guide
                                 WW.
                                Eval Assessment                8               1             1.5              12
                                 TBC Partner
                                 Interview Guide
                                 WW.
                                Ex Assessment                  4               1             1.5               6
                                 CCL Partner
                                 Interview
                                 Guide_WW.
                                Ex Assessment                  4               1             1.5               6
                                 CQM Partner
                                 Interview
                                 Guide_WW.
                                Ex Assessment                  4               1             1.5               6
                                 TBC Partner
                                 Interview
                                 Guide_WW.
                                Ex Assessment                  9               1             1.5            13.5
                                 CCL Partner
                                 Interview Guide
                                 NCHP_ICHP.
                                Ex Assessment                  9               1             1.5            13.5
                                 CQM Partner
                                 Interview Guide
                                 NCHP_ICHP.
                                Ex Assessment                  9               1             1.5            13.5
                                 TBC Partner
                                 Interview Guide
                                 NCHP_ICHP.
                                Comprehensive                330               1             2.5             825
                                 Evaluation
                                 Resource Use
                                 and Cost
                                 Inventory
                                 Tool_Partner.
                                Cost Study                   330               1               1             330
                                 Interview
                                 Guide_Partner.
Learning Collaborative........  Eval Assessment               36               1               1              36
                                 LC Interview
                                 Guide_NCHP_ICHP.
                                Ex Assessment LC              18               1               1              18
                                 Interview Guide
                                 NCHP_ICHP.
                                                 ---------------------------------------------------------------
    Totals....................  ................  ..............  ..............  ..............            2054
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-09857 Filed 5-6-24; 8:45 am]
BILLING CODE 4163-18-P